1715 results for Treatments
Refine Your Search
Heart Disease in Lymphoma Survivors
Matthew Matasar is a hematology and oncology specialist at Memorial Sloan-Kettering Cancer Center in New York City. He has a Translational Research Pr…
Chronic Myeloid Leukemia (CML): Current Strategies & Insights
Join us for a free webinar covering the latest information for patients and caregivers.To register by phone, call (866) 992-9950.Topics CoveredWe invi…
Diagnosed with a Blood Cancer? Important Questions You Might Not Think to Ask
What is my actual diagnosis? Find out your exact diagnosis. Ask your doctor to write down the exact name of your sub-type and take the paper with you.…
Research Grants
More funding for the brightest minds in blood cancer research is a top priority. The next breakthroughs will come from innovative researchers and sci…
Research: Grants
Why our health equity grants are more important than ever before
For 40 years, I’ve poured my life into fighting cancer. Working alongside doctors, nurses, social workers, researchers—and of course patients and thei…
Education Resources
Financial Support
Champions in myeloma research: A conversation with Urvi A. Shah, M.D. M.S.
March is Myeloma Awareness Month, and it’s also Women’s History Month. So what better time to spotlight LLS-funded women scientists who are driving di…
2018 Nobel Prize in Physiology or Medicine: Unleashing the Immune System
The Nobel Prize in Physiology or Medicine has been awarded today to two scientists whose groundbreaking work led to the development of a class of immu…
Improving Blood Cancer Survival Takes More than New Drug Discovery
In my years as a practicing hematologist-oncologist and now as chief medical officer of The Leukemia & Lymphoma Society (LLS), I’ve met many blood can…
What Is Blood Cancer?
Table of ContentsWhat Is Blood Cancer?Types of Blood CancerLeukemiaAcute vs. Chronic LeukemiaLymphomaMultiple MyelomaMyeloproliferative Neoplasms (MPN…
MY FIRST 100 DAYS AS LLS PRESIDENT & CEO
Dear Friends, I’m just over 100 days into my new role as President & CEO of The Leukemia & Lymphoma Society (LLS) and I want to take this moment…
Balancing fiscal responsibility with saving and improving lives
Table of contents:Balancing Fiscal Responsibility with Saving and Improving LivesThe LLS Bold Goal: Accelerate Progress in Blood CancerLLS’s role in p…
An Emerging Target for Myeloma Therapy Could Prove a Game-Changer
Update: In November 2022, the manufacturer (GSK) announced that it had begun a process to withdraw belantamab mafodotin-blmf (Blenrep®) from the U.S. …
Making clinical trials work for patients
Improving access to clinical trials.Clinical trials are the primary vehicle for developing new treatments for patients with cancer and, for many patie…
Advocacy
FDA Approves New Treatment Option For Chronic Graft-Versus-Host-Disease In Patients Ages 12 Years And Older
Rye Brook, N.Y., August 3, 2021 - The U.S. Food and Drug Administration (FDA) recently approved belumosudil (Rezurock™) in patients 12 years or older …
News Release
Finding Support in Community: Walgreens and LLS Show Up for Blood Cancer Patients
We all need a helping hand sometimes. Add on a cancer diagnosis and the everyday suddenly feels... different. In many ways, harder. Fear. Anger. Conf…
Nutrition Advice from a Dietitian & Blood Cancer Survivor
76-year-old Barbara Borrell is a woman who wears many hats – a 50+ year registered dietitian, nutrition consultant and educator, cancer advocate, volu…
Helping Survivors Lead Longer Better Lives
Late last year I had the privilege of attending a special screening of the documentary American Symphony. The film chronicles the experiences of write…
Kymera Therapeutics Receives IND Clearance for KT-333, a STAT3 Degrader, for the Treatment of Hematologic and Solid Malignancies
WATERTOWN, Mass., Nov. 10, 2021 - Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degr…
The Leukemia & Lymphoma Society (LLS) Data and Presence at ASH Showcase Latest Blood Cancer Treatment Breakthroughs
Numerous LLS-funded researchers and Therapy Acceleration Program (TAP) partners will present data on the most recent developments in blood cancer.LLS’…
News Release
IMPACT CLL & MCL: IMPlementing Advances in Cancer Treatment for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
This educational activity is intended for an audience of hematologists/oncologists, members of the oncology multidisciplinary team (MDT; nurses, nurse…
Surviving ALL: An Intimate Look at How Cancer Affected the Careers, Relationships & Fertility of Four Young Adults
A cancer diagnosis is a devastating blow for people of all ages, but presents special challenges for young adults. This period of life is usually a ti…
CAR-T Immunotherapy Showing Positive Results
This week, positive data from a Kite Pharma CAR-T immunotherapy clinical trial was released showing that more than one-third of refractory aggressive …
A New CAR-T Approval Brings Hope for Mantle Cell Lymphoma Patients
The U.S. Food and Drug Administration (FDA) today announced its approval for a breakthrough treatment that will bring the promise of immunotherapy and…
Young Women’s Blood Cancer Support Group - Boston
This online support group is for Boston-area residents.The group will address specific issues related to a blood cancer diagnosis and will provide an …
One Family’s Inspiring Quest to Help Other Families Impacted By Cancer
A nasty cough and extreme fatigue first led Myrna and Lou Binder to bring their 12-year-old son, Jeff, to the doctor for an examination. But the flu-l…